Stock Ticker

  • Loading stock data...

TherapeuticsMD Inc (NYSE:TXMD) Provides Additional Information on TX-004HR Regulatory Update

TherapeuticsMD Inc (NYSE:TXMD) has received a letter from the U.S. Food and Drug Administration (FDA) stating the position of the ongoing reviews of the company’s New Drug Application (NDA) for the TX-004HR. The company expects that FDA will soon conclude their actions on the NDA for TX-004HR which is used to offer treatment in patients […]

TherapeuticsMD Inc (NYSEMKT:TXMD) Expects To Release TX-004HR In 4Q2017

TherapeuticsMD Inc (NYSEMKT:TXMD) a unique women’s healthcare firm reported fourth quarter and full-year fiscal report for 2016. For the year closed December 2016, net revenue was almost $19.4 million versus almost $20.1 million for the previous year. Net revenue for 4Q2016 was almost $4.5 million as against net revenue of around $5.6 million for the […]

Sign Up To Get Our Latest Stocks Alerts